Obagi Medical Products, Inc. — key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2012)

$120.7M

Net Income/Loss (FY2012)

$16.6M

Total Assets (FY2012)

$82.1M

Total Equity (FY2012)

$61.9M

Cash Flows from Operating Activities (FY2012)

$20.4M

Source: Obagi Medical Products, Inc. 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.